Tianjin Chase Sun Pharmaceutical Co.,Ltd 300026.SZ Stock
Tianjin Chase Sun Pharmaceutical Co.,Ltd Price Chart
Tianjin Chase Sun Pharmaceutical Co.,Ltd 300026.SZ Financial and Trading Overview
Contents
- Tianjin Chase Sun Pharmaceutical Co.,Ltd Price Chart
- Tianjin Chase Sun Pharmaceutical Co.,Ltd 300026.SZ Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Tianjin Chase Sun Pharmaceutical Co.,Ltd
- Q&A For Tianjin Chase Sun Pharmaceutical Co.,Ltd Stock
| Tianjin Chase Sun Pharmaceutical Co.,Ltd stock price | 3.73 CNY |
| Previous Close | 5.63 CNY |
| Open | 5.62 CNY |
| Bid | 5.62 CNY x 0 |
| Ask | 5.63 CNY x 0 |
| Day's Range | 5.59 - 5.68 CNY |
| 52 Week Range | 4.87 - 7.95 CNY |
| Volume | 27.51M CNY |
| Avg. Volume | 48.69M CNY |
| Market Cap | 16.88B CNY |
| Beta (5Y Monthly) | -0.09041 |
| PE Ratio (TTM) | 29.578947 |
| EPS (TTM) | 0.17 CNY |
| Forward Dividend & Yield | 0.03 (0.53%) |
| Ex-Dividend Date | May 12, 2023 |
| 1y Target Est | N/A |
300026.SZ Valuation Measures
| Enterprise Value | 17.71B CNY |
| Trailing P/E | 29.578947 |
| Forward P/E | 13.707317 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.5671573 |
| Price/Book (mrq) | 1.9950302 |
| Enterprise Value/Revenue | 2.693 |
| Enterprise Value/EBITDA | 19.287 |
Trading Information
Tianjin Chase Sun Pharmaceutical Co.,Ltd Stock Price History
| Beta (5Y Monthly) | -0.09041 |
| 52-Week Change | -5.37% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 7.95 CNY |
| 52 Week Low | 4.87 CNY |
| 50-Day Moving Average | 5.95 CNY |
| 200-Day Moving Average | 6.1 CNY |
300026.SZ Share Statistics
| Avg. Volume (3 month) | 48.69M CNY |
| Avg. Daily Volume (10-Days) | 38.08M CNY |
| Shares Outstanding | 3B |
| Float | 1.76B |
| Short Ratio | N/A |
| % Held by Insiders | 41.51% |
| % Held by Institutions | 8.85% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.03 |
| Trailing Annual Dividend Yield | 0.53% |
| 5 Year Average Dividend Yield | 71.00% |
| Payout Ratio | 0.21049999 |
| Last Split Factor | 30:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 8.53% |
| Operating Margin (ttm) | 10.17% |
| Gross Margin | 58.19% |
| EBITDA Margin | 13.96% |
Management Effectiveness
| Return on Assets (ttm) | 3.43% |
| Return on Equity (ttm) | 6.65% |
Income Statement
| Revenue (ttm) | 6.58B CNY |
| Revenue Per Share (ttm) | 2.22 CNY |
| Quarterly Revenue Growth (yoy) | -4.20% |
| Gross Profit (ttm) | 6.65B CNY |
| EBITDA | 918.36M CNY |
| Net Income Avi to Common (ttm) | 561.4M CNY |
| Diluted EPS (ttm) | 0.19 |
| Quarterly Earnings Growth (yoy) | -26.40% |
Balance Sheet
| Total Cash (mrq) | 1.3B CNY |
| Total Cash Per Share (mrq) | 0.43 CNY |
| Total Debt (mrq) | 1.92B CNY |
| Total Debt/Equity (mrq) | 22.26 CNY |
| Current Ratio (mrq) | 3.1 |
| Book Value Per Share (mrq) | 2.817 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 927.77M CNY |
| Levered Free Cash Flow (ttm) | 88.77M CNY |
Profile of Tianjin Chase Sun Pharmaceutical Co.,Ltd
| Country | China |
| State | N/A |
| City | Tianjin |
| Address | No. 20, Quanfa Road |
| ZIP | 10200536 |
| Phone | 86 22 5962 3169 |
| Website | https://www.chasesun.cn |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 6146 |
Tianjin Chase Sun Pharmaceutical Co.,Ltd engages in the research, development, production, and marketing of various pharmaceutical products in China. The company offers Chinese herb preparation products, medicinal granules, synthetic drugs, biotech drugs, medical apparatus, and Internet based therapy. It is also involved in the research and development of various drugs in the areas of sepsis, pulmonary hypertension, leukemia, cardiovascular and cerebrovascular diseases, arthritis, ischemic stroke, HCV, vascular disease, psychosis, and chemotherapy, as well as anesthesia drugs and immunomodulators. The company was founded in 1996 and is based in Tianjin, China.
Q&A For Tianjin Chase Sun Pharmaceutical Co.,Ltd Stock
What is a current 300026.SZ stock price?
Tianjin Chase Sun Pharmaceutical Co.,Ltd 300026.SZ stock price today per share is 3.73 CNY.
How to purchase Tianjin Chase Sun Pharmaceutical Co.,Ltd stock?
You can buy 300026.SZ shares on the Shenzhen exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Tianjin Chase Sun Pharmaceutical Co.,Ltd?
The stock symbol or ticker of Tianjin Chase Sun Pharmaceutical Co.,Ltd is 300026.SZ.
Which industry does the Tianjin Chase Sun Pharmaceutical Co.,Ltd company belong to?
The Tianjin Chase Sun Pharmaceutical Co.,Ltd industry is Drug Manufacturers-Specialty & Generic.
How many shares does Tianjin Chase Sun Pharmaceutical Co.,Ltd have in circulation?
The max supply of Tianjin Chase Sun Pharmaceutical Co.,Ltd shares is 3B.
What is Tianjin Chase Sun Pharmaceutical Co.,Ltd Price to Earnings Ratio (PE Ratio)?
Tianjin Chase Sun Pharmaceutical Co.,Ltd PE Ratio is 21.94117500 now.
What was Tianjin Chase Sun Pharmaceutical Co.,Ltd earnings per share over the trailing 12 months (TTM)?
Tianjin Chase Sun Pharmaceutical Co.,Ltd EPS is 0.17 CNY over the trailing 12 months.
Which sector does the Tianjin Chase Sun Pharmaceutical Co.,Ltd company belong to?
The Tianjin Chase Sun Pharmaceutical Co.,Ltd sector is Healthcare.